Positive for COVID-19? monoclonal antibody treatment can keep a mild case from becoming worse

Jenna E. Reno; Hillary D. Lum; J. Jones; Justin Shrader; Bethany Kwan; Adit Ginde

doi:10.25677/rqybq-w6b27

January 1, 2021Open Access

Positive for COVID-19? monoclonal antibody treatment can keep a mild case from becoming worse

View Full Paper

Ask AI

Bookmark

Share

Key Points

The goal is to inform about the effectiveness of monoclonal antibody treatment for COVID-19.
Developed informational flyers in English and Spanish
Outlined how monoclonal antibody treatment works
Provided details on eligibility and costs
Listed treatment centers available
Increased awareness of monoclonal antibody treatment
Improved accessibility and understanding for those eligible
Potentially reduced severity in mild COVID-19 cases with treatment

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

This flyer details monoclonal antibody treatment's impact on mild COVID-19 cases, highlighting treatment access.

Abstract

mAb COVID-19 flyer versions in English and Spanish with detailed information about how mAb treatment works, eligibility, cost, and where to find treatment centers. Folds at 5.75 and 11.5 inches. Last updated fall 2021.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Reno et al. (2021) studied this question.

synapsesocial.com/papers/69b3aca302a1e69014cce8da https://doi.org/10.25677/rqybq-w6b27

View Full Paper

Ask AI

Bookmark

Share

Positive for COVID-19? monoclonal antibody treatment can keep a mild case from becoming worse

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Positive for COVID-19? monoclonal antibody treatment can keep a mild case from becoming worse

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading